Delivery Order SPE2DB22D2211-SPE2DB25FSEVC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form, with a ceiling value of $1,400.63. The contract employs firm fixed pricing and was competitively awarded without set-aside designation. The order is scheduled for completion by September 4, 2025, just one day following the award date of September 3, 2025, indicating an expedited delivery requirement. AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $2,903.88 with a firm fixed price structure. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this competitively awarded contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $4,948.52. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $47,667.15 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.90 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its ongoing federal medical procurement activities...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $1,815.66. The contract was awarded on a firm fixed-price basis with an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, competitively awarded action with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Twinrix vaccine in syringe form, with a contract value of $2,184.12 and an ultimate completion date of July 31, 2025. This non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,472.23 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes under a firm fixed price contract. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a $3,567.95 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEVCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $4,351.64 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of immunization products to support federal medical supply requirements. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. That prime contract serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates significant capability in pharmaceutical distribution to defense and veteran healthcare systems, with consistent delivery order awards across multiple therapeutic domains reflecting its established position as a critical vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/12/25 |